Beck Mack & Oliver LLC Organon & Co. Transaction History

Beck Mack & Oliver LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$31.66 - $38.9 $200,851 - $246,781	-6,344 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$30.45 - $39.36 $104,260 - $134,768	-3,424 Reduced 35.05%	6,344 $222,000
Q4 2021 Jan 28, 2022	SELL	$28.67 - $37.13 $102,552 - $132,814	-3,577 Reduced 26.8%	9,768 $297,000
Q3 2021 Nov 04, 2021	SELL	$28.63 - $35.64 $103,297 - $128,589	-3,608 Reduced 21.28%	13,345 $438,000
Q2 2021 Jul 28, 2021	BUY	$28.45 - $38.0 $482,312 - $644,214	16,953 New	16,953 $513,000

793

192M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Beck Mack & Oliver LLC, based on Form 13F filings with the SEC.

Stay updated on Beck Mack & Oliver LLC with notifications on news.